Australian NSP Survey National Data Report - Nationally initiation of HCV treatment increased in 2016 - Hallo friend NEWS AN INSPIRATION, In the article you read this time with the title Australian NSP Survey National Data Report - Nationally initiation of HCV treatment increased in 2016, we have prepared well for this article you read and download the information therein. hopefully fill posts Article ECONOMY, Article HEALTH, Article POLITICS, Article SPORTS, Article TRAVELING, Article UPDATE, we write can understand. Well, happy reading.

Titre : Australian NSP Survey National Data Report - Nationally initiation of HCV treatment increased in 2016
link : Australian NSP Survey National Data Report - Nationally initiation of HCV treatment increased in 2016

Australian NSP Survey National Data Report - Nationally initiation of HCV treatment increased in 2016

Australian NSP Survey National Data Report 2012 – 2016

Download The Survey

Description 

The Australian Needle and Syringe Program Survey (ANSPS) provides serial point prevalence estimates of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) antibodies and sexual and injecting risk behaviour among people who inject drugs (PWID) in Australia. Conducted annually over a one-two week period in October, all clients attending participating needle and syringe program (NSP) services are invited to complete a brief, anonymous questionnaire and to provide a capillary blood sample for HIV and HCV antibody testing.

This report presents national and state/territory data for the period 2012 to 2016.

Key findings 

• In 2016, 50 Australian Needle and Syringe Programs (NSPs) participated in the ANSPS and 2,210 NSP attendees completed the survey. The response rate was 41%.
• Over the period 2012 to 2016, the median age of survey respondents increased from 38 years to 42 years, with a concurrent decrease in the proportion of young injectors (aged <25 years) from 7% in 2012 to 4% in 2016.
• HIV antibody prevalence remained low and stable nationally, ranging from 1.2% to 2.1% over the period 2012 to 2016
• Hepatitis C virus (HCV) antibody prevalence was stable over the period 2012 to 2016, ranging from 51% to 57%.
• Nationally, the proportion of respondents who reported recent (last 12 months) initiation of HCV treatment was low and stable at 1-3% between 2011-2015, but increased significantly to 22% in 2016, with substantial increases observed in all jurisdictions.

Source

http://ift.tt/2tIHySS

Thus articles Australian NSP Survey National Data Report - Nationally initiation of HCV treatment increased in 2016

that is all articles Australian NSP Survey National Data Report - Nationally initiation of HCV treatment increased in 2016 This time, hopefully can provide benefits to you all. Okay, see you in another article post.

You are now reading the article Australian NSP Survey National Data Report - Nationally initiation of HCV treatment increased in 2016 the link address https://newsaninpiration.blogspot.com/2017/07/australian-nsp-survey-national-data.html

Tweet

Subscribe to receive free email updates: